Details for New Drug Application (NDA): 062549
✉ Email this page to a colleague
NDA 062549 describes KEFLIN IN PLASTIC CONTAINER, which is a drug marketed by Lilly and is included in one NDA. Additional details are available on the KEFLIN IN PLASTIC CONTAINER profile page.
The generic ingredient in KEFLIN IN PLASTIC CONTAINER is cephalothin sodium. There are seven drug master file entries for this compound. Additional details are available on the cephalothin sodium profile page.
The generic ingredient in KEFLIN IN PLASTIC CONTAINER is cephalothin sodium. There are seven drug master file entries for this compound. Additional details are available on the cephalothin sodium profile page.
Summary for 062549
| Tradename: | KEFLIN IN PLASTIC CONTAINER |
| Applicant: | Lilly |
| Ingredient: | cephalothin sodium |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 062549
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 1GM BASE/VIAL | ||||
| Approval Date: | Sep 10, 1985 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 2GM BASE/VIAL | ||||
| Approval Date: | Sep 10, 1985 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
